Rituximab as monotherapy for the treatment of chronic active antibody ‐mediated rejection after kidney transplantation
This article is protected by copyright. All rights reserved.
Source: Transplant International - Category: Transplant Surgery Authors: Yannick D. Muller, Ghaleb Nseir, Samuel Rotman, Julien Vionnet, Mathieu Halfon, Emmanuelle Catana, D éla Golshayan, Jean‐Pierre Venetz, Vincent Aubert, Manuel Pascual Tags: Letter to the Editor Source Type: research
More News: Bone Graft | Kidney Transplant | Kidney Transplantation | Rituxan | Transplant Surgery | Transplants | Urology & Nephrology